On November 29, The Tinley Beverage Company (TNY.C) announced the signing of a new agreement with a licensed manufacturer to expand their production capacity. Tinley’s new manufacturing partner brings…
marijuana
Germany’s growing medical marijuana market has been labelled the number one international business opportunity for Canadian cannabis companies. Reasons include its population and GDP—both of which more than double Canada’s—its…
There have always been rumours. Shrugs. Frowns. Long, drawn breaths. Admission that they were smart, hard working, but…. On stage at the Cambridge House Extraordinary Future show a few…
Cannigistics Agri-Solutions, a subsidiary of Calyx Ventures (CYX.V), introduced its cannabis ‘message board’ app to third-party partners for testing today. Named Leafnet, the app is like Slack for the…
One thing I love about US-focused cannabis roll-up C21 Investments (CXXI.C) is their ‘coming through’ attitude. They’re buying up US weed assets quickly, and don’t mess around with small…
Beleave (BE.C) has been undervalued for some time. Like, absurdly undervalued. Criminally undervalued. So undervalued it was suspicious. For $55m (yesterday) you could have owned a small licensed 14.5k…
If you want CBD, which is the stuff in cannabis that makes you healthier but that doesn’t get you stoned, hemp has as much of the stuff as commercial…
When I call up a CEO and hear their pitch, I mentally rank where that pitch sits in terms of intelligence, opportunity, trustworthiness, alongside all the pitches I’ve heard…
Had a conversation on the phone with Stephen Pynn, VP of Corporate Devs at Pure Global (PURE.V) this week that got me thinking. Pure has had an up and down…
A week ago, US dispensary roll-up play MedMen (MMEN.C) closed an $86m financing and a $99.95m loan to help them complete a $682m deal to buy PharmaCann, which has…